US Physical Therapy (USPH) Earnings Date & Reports

Key Takeaways

• U.S. Physical Therapy reported third quarter 2026 revenue of $222.6 million, up 12.9% year over year and above the roughly $214.5 million consensus estimate.
• Adjusted earnings per share (EPS) came in at $0.80, exceeding analyst expectations that ranged near $0.73–$0.76.
• Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) reached approximately $27.8 million, topping the consensus estimate of about $26.6 million.
• Full-year adjusted EBITDA guidance held near a $104 million midpoint, in line with Wall Street expectations.
• Patient volumes reached a record high, with 72 hospital-affiliated clinics generating $25 million in quarterly revenue.
• For more on this ticker, explore its Major News, Today's Price Move, Price Targets, and Forecast pages.
• Discover Trending AI Robots for automated, AI-driven trading signals and market ideas.

Earnings Context and Why It Matters

U.S. Physical Therapy is a national operator of outpatient physical therapy clinics and a provider of industrial injury prevention services, running roughly 799 locations across 45 states. Its third quarter results matter because they offer a read on patient demand, reimbursement trends, and the company's expanding hospital-affiliation strategy. The report follows several quarters in which revenue grew steadily even as GAAP (Generally Accepted Accounting Principles) earnings were weighed down by acquisition-related fair-value adjustments. With Medicare rate changes and strategic hospital alliances rolling through the business, investors were watching closely for evidence that these initiatives were translating into higher visits, stronger revenue per visit, and improving profitability.

Reported Results

For the three months ended September 30, 2026, U.S. Physical Therapy reported total net revenue of $222.6 million, a 12.9% increase from $197.1 million in the prior-year quarter and comfortably ahead of the consensus estimate of roughly $214.5 million. Adjusted EPS of $0.80 beat expectations of approximately $0.73–$0.76, while adjusted EBITDA of about $27.8 million surpassed the roughly $26.6 million consensus figure, reflecting a 12.5% margin.

The top-line strength was driven by record patient visits and record revenue per visit. Management noted that 72 clinics operating under hospital-affiliation agreements contributed $25 million in revenue during the quarter. On a GAAP basis, net income attributable to shareholders was approximately $11.0 million, down from $13.1 million a year earlier, reflecting acquisition-related costs and fair-value adjustments that do not affect the adjusted figures. The company also reiterated full-year adjusted EBITDA guidance near a $104 million midpoint, which was consistent with analyst forecasts.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool designed to help traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to uncover new opportunities aligned with your investing approach.

Market Reaction and Investor Sentiment

The third quarter print was received favorably, as U.S. Physical Therapy delivered both a top- and bottom-line beat while reaffirming full-year EBITDA guidance. The combination of record visits and higher revenue per visit reinforced the view that the company's hospital-affiliation model is beginning to scale as management described. Shares had risen roughly 11% over the three months leading into the report, suggesting investors had already positioned for improving fundamentals. The strongest positive signal came from the sequential ramp in hospital-affiliated clinic revenue, which management expects to grow as referral volumes rise and additional clinics are incorporated into existing agreements.

Forward Outlook and Key Factors to Monitor

Looking ahead, investors should monitor the pace at which the company's hospital-affiliation pipeline converts into new clinics and incremental revenue. Management indicated that the $25 million generated by 72 affiliated clinics in the quarter is expected to increase meaningfully as referral volumes build and new agreements are signed.

Cost trends remain an important swing factor. Salaries and related costs, plus rent, supplies, and contract labor, continue to represent the bulk of operating expenses, so labor availability and wage inflation will influence margins in coming quarters. Reimbursement dynamics, including Medicare rate updates and commercial payer mix, are also worth tracking given their direct effect on revenue per visit.

Finally, the company's acquisition strategy introduces GAAP volatility through fair-value adjustments and redeemable non-controlling interests, so investors should distinguish between reported net income and adjusted operating results when evaluating performance. No price predictions are offered here, but these are the key variables likely to shape sentiment around future quarterly earnings.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations